Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Dotarem Safety

NCT03048006 is registered in ClinicalTrials.gov with Guerbet as lead sponsor.

NCT NCT03048006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03048006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Dotarem Safety
Lead sponsor
Guerbet
Phase
Observational
Overall status
Completed
Start date
January 31, 2011
Completion date
December 31, 2013
Enrollment
44,456 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

contrast-enhanced mri with dotarem